766 related articles for article (PubMed ID: 12750262)
1. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
[TBL] [Abstract][Full Text] [Related]
2. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.
Liu B; Edgerton S; Yang X; Kim A; Ordonez-Ercan D; Mason T; Alvarez K; McKimmey C; Liu N; Thor A
Cancer Res; 2005 Feb; 65(3):879-86. PubMed ID: 15705886
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice.
Kosanke S; Edgerton SM; Moore D; Yang X; Mason T; Alvarez K; Jones L; Kim A; Thor AD
Comp Med; 2004 Jun; 54(3):280-7. PubMed ID: 15253274
[TBL] [Abstract][Full Text] [Related]
4. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats.
Manjanatha MG; Shelton S; Bishop ME; Lyn-Cook LE; Aidoo A
Carcinogenesis; 2006 Dec; 27(12):2555-64. PubMed ID: 17127718
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.
Ménard S; Aiello P; Tagliabue E; Rumio C; Lollini PL; Colnaghi MI; Balsari A
Cancer Res; 2000 Jan; 60(2):273-5. PubMed ID: 10667575
[TBL] [Abstract][Full Text] [Related]
7. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
8. Modulation of mammary tumor development in Tg.NK (MMTV/c-neu) mice by dietary fatty acids and life stage-specific exposure to phytoestrogens.
Luijten M; Verhoef A; Dormans JA; Beems RB; Cremers HW; Nagelkerke NJ; Adlercreutz H; Peñalvo JL; Piersma AH
Reprod Toxicol; 2007; 23(3):407-13. PubMed ID: 17229545
[TBL] [Abstract][Full Text] [Related]
9. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats.
Manjanatha M; Shelton S; Bishop M; Lyn-Cook L; Aidoo A
Carcinogenesis; 2006 Oct; 27(10):1970-9. PubMed ID: 16709578
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Lubet RA; Boring D; Steele VE; Ruppert JM; Juliana MM; Grubbs CJ
Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723
[TBL] [Abstract][Full Text] [Related]
11. A transgenic mouse model for mammary carcinogenesis.
Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
13. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
14. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
15. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
Wu K; Zhang Y; Xu XC; Hill J; Celestino J; Kim HT; Mohsin SK; Hilsenbeck SG; Lamph WW; Bissonette R; Brown PH
Cancer Res; 2002 Nov; 62(22):6376-80. PubMed ID: 12438218
[TBL] [Abstract][Full Text] [Related]
16. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
17. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
Chiesa G; Rigamonti E; Lovati MR; Disconzi E; Soldati S; Sacco MG; Catò EM; Patton V; Scanziani E; Vezzoni P; Arnoldi A; Locati D; Sirtori CR
Mol Nutr Food Res; 2008 Oct; 52(10):1121-9. PubMed ID: 18655005
[TBL] [Abstract][Full Text] [Related]
18. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
Chen J; Hui E; Ip T; Thompson LU
Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
[TBL] [Abstract][Full Text] [Related]
19. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
20. Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis.
Alexandersen P; Haarbo J; Breinholt V; Christiansen C
Climacteric; 2001 Jun; 4(2):151-9. PubMed ID: 11428179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
